The respiratory syncytial virus surge in Austria, 2022, was caused by lineages present before the COVID-19 pandemic
Preprint
Abstract
In 2022, Austria experienced a severe respiratory syncytial virus (RSV) epidemic with an earlier-than-usual start and increased numbers of paediatric patients in emergency departments. Nationwide multiyear genomic surveillance revealed that the surge was driven by RSV-B, however genotypes consisted of multiple lineages that were circulating prior to the pandemic.Keywords
All Related Versions
- Published version: Journal of Medical Virology, 95 (6), e28830.
This publication has 8 references indexed in Scilit:
- Early and intense epidemic of respiratory syncytial virus (RSV) in Denmark, August to December 2022Eurosurveillance, 2023
- Genomic characterization of respiratory syncytial virus 2022-2023 outbreak in Washington State, USAmedRxiv, 2022
- Decline of RSV-specific antibodies during the COVID-19 pandemicThe Lancet Infectious Diseases, 2022
- The effects of the COVID-19 pandemic on community respiratory virus activityNature Reviews Microbiology, 2022
- Waning Immunity Against Respiratory Syncytial Virus During the Coronavirus Disease 2019 PandemicThe Journal of Infectious Diseases, 2022
- Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic — United States, 2020–2021MMWR. Morbidity and Mortality Weekly Report, 2021
- Towards a unified classification for human respiratory syncytial virus genotypesVirus Evolution, 2020
- Toward unified molecular surveillance of RSV: A proposal for genotype definitionInfluenza and Other Respiratory Viruses, 2020